JP2020519583A5 - - Google Patents

Download PDF

Info

Publication number
JP2020519583A5
JP2020519583A5 JP2019561210A JP2019561210A JP2020519583A5 JP 2020519583 A5 JP2020519583 A5 JP 2020519583A5 JP 2019561210 A JP2019561210 A JP 2019561210A JP 2019561210 A JP2019561210 A JP 2019561210A JP 2020519583 A5 JP2020519583 A5 JP 2020519583A5
Authority
JP
Japan
Prior art keywords
compound
formula
amine compound
alkyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2019561210A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020519583A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/032407 external-priority patent/WO2018209290A1/en
Publication of JP2020519583A publication Critical patent/JP2020519583A/ja
Publication of JP2020519583A5 publication Critical patent/JP2020519583A5/ja
Abandoned legal-status Critical Current

Links

JP2019561210A 2017-05-12 2018-05-11 (3r,4s)−3−アセトアミド−4−アリル−n−(tert−ブチル)ピロリジン−3−カルボキサミドの製造方法 Abandoned JP2020519583A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762505282P 2017-05-12 2017-05-12
US62/505,282 2017-05-12
PCT/US2018/032407 WO2018209290A1 (en) 2017-05-12 2018-05-11 Method of preparing (3r,4s)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide

Publications (2)

Publication Number Publication Date
JP2020519583A JP2020519583A (ja) 2020-07-02
JP2020519583A5 true JP2020519583A5 (enExample) 2021-07-26

Family

ID=62387001

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019561210A Abandoned JP2020519583A (ja) 2017-05-12 2018-05-11 (3r,4s)−3−アセトアミド−4−アリル−n−(tert−ブチル)ピロリジン−3−カルボキサミドの製造方法

Country Status (21)

Country Link
US (3) US10494339B2 (enExample)
EP (1) EP3621954B1 (enExample)
JP (1) JP2020519583A (enExample)
KR (1) KR20200008578A (enExample)
CN (1) CN110709383A (enExample)
AU (1) AU2018265873A1 (enExample)
BR (1) BR112019023582A2 (enExample)
CA (1) CA3062851A1 (enExample)
CL (1) CL2019003212A1 (enExample)
CO (1) CO2019013923A2 (enExample)
CR (1) CR20190562A (enExample)
EA (1) EA201992695A1 (enExample)
IL (2) IL278757B (enExample)
MA (1) MA48626A (enExample)
MX (1) MX2019013533A (enExample)
PE (1) PE20200339A1 (enExample)
PH (1) PH12019502505A1 (enExample)
SG (1) SG10201912946TA (enExample)
TW (1) TW201900609A (enExample)
WO (1) WO2018209290A1 (enExample)
ZA (1) ZA201908267B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20160305T1 (hr) 2010-10-26 2016-07-01 Mars, Incorporated Borati kao inhibitori arginaze
CN114989205A (zh) 2016-12-22 2022-09-02 卡里塞拉生物科学股份公司 用于抑制精氨酸酶活性的组合物和方法
KR20200008578A (ko) * 2017-05-12 2020-01-28 칼리테라 바이오사이언시즈, 인코포레이티드 (3R,4S)-3-아세트아미도-4-알릴-N-(tert-부틸)피롤리딘-3-카복스아미드의 제조방법
WO2019186497A1 (en) 2018-03-29 2019-10-03 Oncoarendi Therapeutics S.A. Dipeptide piperidine derivatives
CN110734456A (zh) * 2019-11-06 2020-01-31 南京谷睿生物科技有限公司 一种化合物及其制备方法和医药上的应用
TW202216662A (zh) 2020-07-17 2022-05-01 美商英塞特公司 製備精胺酸酶抑制劑及其合成中間物之方法
CN113866289A (zh) * 2021-09-03 2021-12-31 上海凌凯医药科技有限公司 2,3-二苯甲酰氧基-4-二甲基氨基-4-氧代丁酸的手性分离检测方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9797998A (en) 1997-10-10 1999-05-03 Trustees Of The University Of Pennsylvania, The Compositions and methods for inhibiting arginase activity
US20040063666A1 (en) 1998-10-09 2004-04-01 David Christianson Compositions for inhibiting arginase activity
CA2415174A1 (en) 2000-07-06 2002-01-17 Thomas W. Bell Methods and kits for the detection of arginine compounds
CA2431080A1 (en) 2003-06-02 2004-12-02 Catherine Adele O'brien Enhancement of anticancer immunity through inhibition of arginase
WO2007005620A2 (en) 2005-07-01 2007-01-11 The Johns Hopkins University Arginase ii: a target treatment of aging heart and heart failure
LT2389352T (lt) 2009-01-26 2019-06-10 The Trustees Of The University Of Pennsylvania Arginazės inhibitoriai ir naudojimo būdai
SG10201503168VA (en) 2010-04-22 2015-06-29 Mars Inc Inhibitors of arginase and their therapeutic applications
HRP20160305T1 (hr) 2010-10-26 2016-07-01 Mars, Incorporated Borati kao inhibitori arginaze
CA2824599C (en) 2010-12-31 2020-03-10 Astrazeneca Uk Limited Arginase inhibitors and methods of use thereof
WO2013059437A1 (en) 2011-10-19 2013-04-25 Mars, Incorporated Inhibitors of arginase and their therapeutic applications
JP6073343B2 (ja) 2011-10-20 2017-02-01 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC サーチュイン調節因子としての置換された二環式アザ複素環およびアナログ
CN104540836B (zh) * 2012-04-18 2016-11-09 马尔斯公司 作为精氨酸酶抑制剂的环约束类似物
EA201690746A1 (ru) 2013-10-25 2016-12-30 Фармасайкликс Элэлси Лечение с применением ингибиторов тирозинкиназы брутона и иммунотерапии
CN105879030A (zh) 2014-09-30 2016-08-24 复旦大学 治疗肿瘤的增效药物复合物及其制备方法
CN107405404A (zh) 2015-03-20 2017-11-28 塞米·欧尤·奥皮约 苏拉明和精氨酸酶抑制剂在恶性肿瘤中的用途
US10143699B2 (en) * 2015-06-23 2018-12-04 Calithera Biosciences, Inc. Compositions and methods for inhibiting arginase activity
SG11201802961PA (en) * 2015-10-30 2018-05-30 Calithera Biosciences Inc Compositions and methods for inhibiting arginase activity
KR20200008578A (ko) * 2017-05-12 2020-01-28 칼리테라 바이오사이언시즈, 인코포레이티드 (3R,4S)-3-아세트아미도-4-알릴-N-(tert-부틸)피롤리딘-3-카복스아미드의 제조방법

Similar Documents

Publication Publication Date Title
JP2020519583A5 (enExample)
US20040122226A1 (en) Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
RU2718058C2 (ru) Способ синтеза производных рапамицина
KR20110116167A (ko) 2-아실아미노-3-디페닐프로판산의 제조 및 분할 방법
BRPI0611166B1 (pt) Processo para isolar (as,ssr)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoxi-alfa-1-naftalenil- betafenil-3-quinolinaetanol
JP2012515142A5 (enExample)
IL278757A (en) Method for Preparation (3R, 4S) –3– Acetamido – 4 – Idyl– N– (Tert-Butyl) Pyrolidine – 3 – Carboxamide
TW202442640A (zh) Ras抑制劑之合成
WO2023001131A1 (zh) 草铵膦的制备方法
JP2022116171A5 (enExample)
RU2020121714A (ru) Способ получения (3s)-3-(4-хлор-3-{ [(2s,3r)-2-(4-хлорфенил)-4,4,4-трифтор-3-метилбутаноил]амино} фенил)-3-циклопропилпропановой кислоты и её кристаллической формы для применения в качестве фармацевтического активного вещества
JP6148351B2 (ja) 置換ピロリジン−2−カルボキサミドの不斉合成
ES2965478T3 (es) Protodescarboxilación catalizada por metales de transición de derivados del ácido alfa-halo-acrílico
KR20210014646A (ko) 키랄 2-[(헤테로)아릴알킬설파닐]피리미딘의 입체선택성 제조 공정 및 이로부터 얻을 수 있는 생성물
JP2008506641A (ja) 塩化物含量が低いオニウム塩の製造方法
García-Egido et al. Synthesis of cyanoformamides from primary amines and carbon dioxide under mild conditions. Synthesis of ceratinamine
WO2005044757A1 (fr) Procede diastereoselectif de preparation d'olefines par la reaction d'horner-wadsworth-emmons mettant en oeuvre un phosphonate particulier qui ameliore la diastereoselectivite a toutes temperatures y compris a temperature ambiante
WO2004026806A2 (fr) Procede de preparation diastereoselectif d'olefines par la reaction d'horner-wadsworth-emmons comprenant un ajout d'un agent sequestrant tris-(polyoxaalkyl)-amine
JP4092739B2 (ja) アゾエステル化合物の新規な製造方法
JP6000248B2 (ja) 2,3−ジアミノプロピオン酸誘導体のエナンチオマ体の製造方法
JP2007506794A5 (enExample)
US20220089607A1 (en) Process for the preparation of high pure eribulin and its mesylate salt
CN116478207B (zh) 一种草铵膦的制备方法
WO2014103812A1 (ja) ピラゾール化合物の結晶の製造方法
JPS5846045A (ja) ラセミ化合物(1rs,2sr)−2−アミノ−1−フエニル−プロパン−1−オ−ルの分割法